BACKGROUND: Cutaneous adverse drug reactions (CADRs) comprise about 30% of all adverse drug reactions and observed in 2-3% of hospitalized patients by wide variety of offending agents. AIMS: To study the clinical patterns, causative drugs and their association with autoimmune diseases in CADR patients. MATERIALS AND METHODS: A total of 174 CADR patients who presented to the dermatology OPD over a period of 18 months (1 July 2015 to 31 Dec 2016) were considered for the study. Detailed history, clinical examination, hematological, and biochemical investigations were recorded. The venereal disease research laboratory test, HIV (ELISA), and histopathological examination were done wherever indicated. CONCLUSION: value = 0.004) was also observed.
No takes yet. Share an insight, caveat, or question.
Rana et al. (2021) studied this question.